Aptevo Therapeutics Inc. buy kyron7htx
Start price
06.02.19
/
50%
€23.61
Target price
14.02.19
€63.14
Performance (%)
-10.63%
End price
14.02.19
€21.10
Summary
This prediction ended on 14.02.19 with a price of €21.10. The prediction for Aptevo Therapeutics Inc. disappointed with a performance of -10.63%. kyron7htx has 50% into this predictionUnfortunately, there is no listed company called Aptevo Therapeutics with the symbol APVOV. However, there is a company with the symbol APVO. Aptevo Therapeutics is a biotechnology company that focuses on the discovery, development, and commercialization of novel oncology and hematology therapeutics. The company's product portfolio includes treatments for a variety of conditions such as hemophilia, immune disorders, and cancer. Their approach involves using genetically engineered proteins to target specific diseases and their therapies have shown promising results in clinical trials.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Aptevo Therapeutics Inc. | - | - | - | - |
| iShares Core DAX® | -0.870% | -1.700% | 10.560% | 13.129% |
| iShares Nasdaq 100 | -5.561% | -3.604% | 34.335% | 39.856% |
| iShares Nikkei 225® | -6.138% | -7.732% | 16.215% | 0.044% |
| iShares S&P 500 | -3.141% | -2.011% | 24.534% | 39.859% |
Comments by kyron7htx for this prediction
In the thread Aptevo Therapeutics Inc diskutieren
Boden
auch hier erreicht?
(Stop Loss Kurs erreicht)
Stopped prediction by kyron7htx for Aptevo Therapeutics Inc.
Aptevo Therapeutics Inc.
Start price
Target price
Perf. (%)
€11.24
02.07.19
02.07.19
€25.26
04.11.21
04.11.21
38.37%
17.07.21
17.07.21
Aptevo Therapeutics Inc.
Start price
Target price
Perf. (%)
€20.58
16.02.19
16.02.19
€50.51
13.03.19
13.03.19
-46.93%
13.03.19
13.03.19